Table of Content

1 PD-1 and PDL-1 Inhibitors Market Overview
1.1 PD-1 and PDL-1 Inhibitors Product Overview
1.2 PD-1 and PDL-1 Inhibitors Market Segment by Type
1.2.1 Pembrolizumab
1.2.2 Nivolumab
1.2.3 Atezolizumab
1.2.4 Durvalumab
1.2.5 Avelumab
1.3 Global PD-1 and PDL-1 Inhibitors Market Size by Type
1.3.1 Global PD-1 and PDL-1 Inhibitors Market Size Overview by Type (2018-2029)
1.3.2 Global PD-1 and PDL-1 Inhibitors Historic Market Size Review by Type (2018-2024)
1.3.3 Global PD-1 and PDL-1 Inhibitors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PD-1 and PDL-1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.2 Europe PD-1 and PDL-1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific PD-1 and PDL-1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.4 Latin America PD-1 and PDL-1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Breakdown by Type (2018-2024)
2 Global PD-1 and PDL-1 Inhibitors Market Competition by Company
2.1 Global Top Players by PD-1 and PDL-1 Inhibitors Sales (2018-2024)
2.2 Global Top Players by PD-1 and PDL-1 Inhibitors Revenue (2018-2024)
2.3 Global Top Players by PD-1 and PDL-1 Inhibitors Price (2018-2024)
2.4 Global Top Manufacturers PD-1 and PDL-1 Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 PD-1 and PDL-1 Inhibitors Market Competitive Situation and Trends
2.5.1 PD-1 and PDL-1 Inhibitors Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by PD-1 and PDL-1 Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-1 and PDL-1 Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into PD-1 and PDL-1 Inhibitors Market
2.8 Key Manufacturers PD-1 and PDL-1 Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PD-1 and PDL-1 Inhibitors Status and Outlook by Region
3.1 Global PD-1 and PDL-1 Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global PD-1 and PDL-1 Inhibitors Historic Market Size by Region
3.2.1 Global PD-1 and PDL-1 Inhibitors Sales in Volume by Region (2018-2024)
3.2.2 Global PD-1 and PDL-1 Inhibitors Sales in Value by Region (2018-2024)
3.2.3 Global PD-1 and PDL-1 Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global PD-1 and PDL-1 Inhibitors Forecasted Market Size by Region
3.3.1 Global PD-1 and PDL-1 Inhibitors Sales in Volume by Region (2024-2029)
3.3.2 Global PD-1 and PDL-1 Inhibitors Sales in Value by Region (2024-2029)
3.3.3 Global PD-1 and PDL-1 Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global PD-1 and PDL-1 Inhibitors by Application
4.1 PD-1 and PDL-1 Inhibitors Market Segment by Application
4.1.1 Stomach Cancer
4.1.2 Liver Cancer
4.1.3 Kidney Ccancer
4.1.4 Bladder Cancer
4.1.5 Cervical Cancer
4.1.6 Other
4.2 Global PD-1 and PDL-1 Inhibitors Market Size by Application
4.2.1 Global PD-1 and PDL-1 Inhibitors Market Size Overview by Application (2018-2029)
4.2.2 Global PD-1 and PDL-1 Inhibitors Historic Market Size Review by Application (2018-2024)
4.2.3 Global PD-1 and PDL-1 Inhibitors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PD-1 and PDL-1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.2 Europe PD-1 and PDL-1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific PD-1 and PDL-1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.4 Latin America PD-1 and PDL-1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Breakdown by Application (2018-2024)
5 North America PD-1 and PDL-1 Inhibitors by Country
5.1 North America PD-1 and PDL-1 Inhibitors Historic Market Size by Country
5.1.1 North America PD-1 and PDL-1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America PD-1 and PDL-1 Inhibitors Sales in Volume by Country (2018-2024)
5.1.3 North America PD-1 and PDL-1 Inhibitors Sales in Value by Country (2018-2024)
5.2 North America PD-1 and PDL-1 Inhibitors Forecasted Market Size by Country
5.2.1 North America PD-1 and PDL-1 Inhibitors Sales in Volume by Country (2024-2029)
5.2.2 North America PD-1 and PDL-1 Inhibitors Sales in Value by Country (2024-2029)
6 Europe PD-1 and PDL-1 Inhibitors by Country
6.1 Europe PD-1 and PDL-1 Inhibitors Historic Market Size by Country
6.1.1 Europe PD-1 and PDL-1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe PD-1 and PDL-1 Inhibitors Sales in Volume by Country (2018-2024)
6.1.3 Europe PD-1 and PDL-1 Inhibitors Sales in Value by Country (2018-2024)
6.2 Europe PD-1 and PDL-1 Inhibitors Forecasted Market Size by Country
6.2.1 Europe PD-1 and PDL-1 Inhibitors Sales in Volume by Country (2024-2029)
6.2.2 Europe PD-1 and PDL-1 Inhibitors Sales in Value by Country (2024-2029)
7 Asia-Pacific PD-1 and PDL-1 Inhibitors by Region
7.1 Asia-Pacific PD-1 and PDL-1 Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific PD-1 and PDL-1 Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific PD-1 and PDL-1 Inhibitors Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific PD-1 and PDL-1 Inhibitors Sales in Value by Region (2018-2024)
7.2 Asia-Pacific PD-1 and PDL-1 Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific PD-1 and PDL-1 Inhibitors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific PD-1 and PDL-1 Inhibitors Sales in Value by Region (2024-2029)
8 Latin America PD-1 and PDL-1 Inhibitors by Country
8.1 Latin America PD-1 and PDL-1 Inhibitors Historic Market Size by Country
8.1.1 Latin America PD-1 and PDL-1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America PD-1 and PDL-1 Inhibitors Sales in Volume by Country (2018-2024)
8.1.3 Latin America PD-1 and PDL-1 Inhibitors Sales in Value by Country (2018-2024)
8.2 Latin America PD-1 and PDL-1 Inhibitors Forecasted Market Size by Country
8.2.1 Latin America PD-1 and PDL-1 Inhibitors Sales in Volume by Country (2024-2029)
8.2.2 Latin America PD-1 and PDL-1 Inhibitors Sales in Value by Country (2024-2029)
9 Middle East and Africa PD-1 and PDL-1 Inhibitors by Country
9.1 Middle East and Africa PD-1 and PDL-1 Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa PD-1 and PDL-1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa PD-1 and PDL-1 Inhibitors Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa PD-1 and PDL-1 Inhibitors Sales in Value by Country (2018-2024)
9.2 Middle East and Africa PD-1 and PDL-1 Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa PD-1 and PDL-1 Inhibitors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa PD-1 and PDL-1 Inhibitors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline plc
10.1.1 GlaxoSmithKline plc Company Information
10.1.2 GlaxoSmithKline plc Introduction and Business Overview
10.1.3 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Products Offered
10.1.5 GlaxoSmithKline plc Recent Development
10.2 Bristol-Myers Squibb Company
10.2.1 Bristol-Myers Squibb Company Company Information
10.2.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.2.3 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Products Offered
10.2.5 Bristol-Myers Squibb Company Recent Development
10.3 Arcus Biosciences, Inc.
10.3.1 Arcus Biosciences, Inc. Company Information
10.3.2 Arcus Biosciences, Inc. Introduction and Business Overview
10.3.3 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Products Offered
10.3.5 Arcus Biosciences, Inc. Recent Development
10.4 Agenus Inc
10.4.1 Agenus Inc Company Information
10.4.2 Agenus Inc Introduction and Business Overview
10.4.3 Agenus Inc PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Agenus Inc PD-1 and PDL-1 Inhibitors Products Offered
10.4.5 Agenus Inc Recent Development
10.5 F. Hoffmann-La Roche Ltd
10.5.1 F. Hoffmann-La Roche Ltd Company Information
10.5.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
10.5.3 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.5.4 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Products Offered
10.5.5 F. Hoffmann-La Roche Ltd Recent Development
10.6 Astra Zeneca PLC
10.6.1 Astra Zeneca PLC Company Information
10.6.2 Astra Zeneca PLC Introduction and Business Overview
10.6.3 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Products Offered
10.6.5 Astra Zeneca PLC Recent Development
10.7 Beigene Ltd
10.7.1 Beigene Ltd Company Information
10.7.2 Beigene Ltd Introduction and Business Overview
10.7.3 Beigene Ltd PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Beigene Ltd PD-1 and PDL-1 Inhibitors Products Offered
10.7.5 Beigene Ltd Recent Development
10.8 Incyte Corporation
10.8.1 Incyte Corporation Company Information
10.8.2 Incyte Corporation Introduction and Business Overview
10.8.3 Incyte Corporation PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Incyte Corporation PD-1 and PDL-1 Inhibitors Products Offered
10.8.5 Incyte Corporation Recent Development
10.9 Biocad
10.9.1 Biocad Company Information
10.9.2 Biocad Introduction and Business Overview
10.9.3 Biocad PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Biocad PD-1 and PDL-1 Inhibitors Products Offered
10.9.5 Biocad Recent Development
10.10 CStone Pharmaceuticals
10.10.1 CStone Pharmaceuticals Company Information
10.10.2 CStone Pharmaceuticals Introduction and Business Overview
10.10.3 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.10.4 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Products Offered
10.10.5 CStone Pharmaceuticals Recent Development
10.11 Ono Pharmaceutical
10.11.1 Ono Pharmaceutical Company Information
10.11.2 Ono Pharmaceutical Introduction and Business Overview
10.11.3 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Products Offered
10.11.5 Ono Pharmaceutical Recent Development
10.12 Merck
10.12.1 Merck Company Information
10.12.2 Merck Introduction and Business Overview
10.12.3 Merck PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Merck PD-1 and PDL-1 Inhibitors Products Offered
10.12.5 Merck Recent Development
10.13 Shanghai Junshi Bioscience Co. Ltd
10.13.1 Shanghai Junshi Bioscience Co. Ltd Company Information
10.13.2 Shanghai Junshi Bioscience Co. Ltd Introduction and Business Overview
10.13.3 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Products Offered
10.13.5 Shanghai Junshi Bioscience Co. Ltd Recent Development
10.14 Shanghai Henlius Biotech, Inc.
10.14.1 Shanghai Henlius Biotech, Inc. Company Information
10.14.2 Shanghai Henlius Biotech, Inc. Introduction and Business Overview
10.14.3 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Products Offered
10.14.5 Shanghai Henlius Biotech, Inc. Recent Development
10.15 Jiangsu HengRui Medicine Co., Ltd.
10.15.1 Jiangsu HengRui Medicine Co., Ltd. Company Information
10.15.2 Jiangsu HengRui Medicine Co., Ltd. Introduction and Business Overview
10.15.3 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Products Offered
10.15.5 Jiangsu HengRui Medicine Co., Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PD-1 and PDL-1 Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PD-1 and PDL-1 Inhibitors Industrial Chain Analysis
11.4 PD-1 and PDL-1 Inhibitors Market Dynamics
11.4.1 PD-1 and PDL-1 Inhibitors Industry Trends
11.4.2 PD-1 and PDL-1 Inhibitors Market Drivers
11.4.3 PD-1 and PDL-1 Inhibitors Market Challenges
11.4.4 PD-1 and PDL-1 Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PD-1 and PDL-1 Inhibitors Distributors
12.3 PD-1 and PDL-1 Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Pembrolizumab
Table 2. Major Company of Nivolumab
Table 3. Major Company of Atezolizumab
Table 4. Major Company of Durvalumab
Table 5. Major Company of Avelumab
Table 6. Global PD-1 and PDL-1 Inhibitors Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global PD-1 and PDL-1 Inhibitors Sales by Type (2018-2024) & (K Units)
Table 8. Global PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Type (2018-2024)
Table 9. Global PD-1 and PDL-1 Inhibitors Sales by Type (2018-2024) & (US& Million)
Table 10. Global PD-1 and PDL-1 Inhibitors Market Share in Value by Type (2018-2024)
Table 11. Global PD-1 and PDL-1 Inhibitors Price by Type (2018-2024) & (US$/Unit)
Table 12. Global PD-1 and PDL-1 Inhibitors Sales by Type (2024-2029) & (K Units)
Table 13. Global PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Type (2024-2029)
Table 14. Global PD-1 and PDL-1 Inhibitors Sales by Type (2024-2029) & (US$ Million)
Table 15. Global PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Type (2024-2029)
Table 16. Global PD-1 and PDL-1 Inhibitors Price by Type (2024-2029) & (US$/Unit)
Table 17. North America PD-1 and PDL-1 Inhibitors Sales by Type (2018-2024) & (K Units)
Table 18. North America PD-1 and PDL-1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe PD-1 and PDL-1 Inhibitors Sales (K Units) by Type (2018-2024)
Table 20. Europe PD-1 and PDL-1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America PD-1 and PDL-1 Inhibitors Sales (K Units) by Type (2018-2024)
Table 24. Latin America PD-1 and PDL-1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 27. Global PD-1 and PDL-1 Inhibitors Sales by Company (2018-2024) & (K Units)
Table 28. Global PD-1 and PDL-1 Inhibitors Sales Share by Company (2018-2024)
Table 29. Global PD-1 and PDL-1 Inhibitors Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global PD-1 and PDL-1 Inhibitors Revenue Share by Company (2018-2024)
Table 31. Global Market PD-1 and PDL-1 Inhibitors Price by Company (2018-2024) & (US$/Unit)
Table 32. Global PD-1 and PDL-1 Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global PD-1 and PDL-1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-1 and PDL-1 Inhibitors as of 2022)
Table 35. Date of Key Manufacturers Enter into PD-1 and PDL-1 Inhibitors Market
Table 36. Key Manufacturers PD-1 and PDL-1 Inhibitors Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global PD-1 and PDL-1 Inhibitors Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Global PD-1 and PDL-1 Inhibitors Sales by Region (2018-2024) & (K Units)
Table 40. Global PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 41. Global PD-1 and PDL-1 Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 42. Global PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 43. Global PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 44. Global PD-1 and PDL-1 Inhibitors Sales by Region (2024-2029) & (K Units)
Table 45. Global PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 46. Global PD-1 and PDL-1 Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 47. Global PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 48. Global PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 49. Global PD-1 and PDL-1 Inhibitors Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 50. Global PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) & (K Units)
Table 51. Global PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Application (2018-2024)
Table 52. Global PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 53. Global PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Application (2018-2024)
Table 54. Global PD-1 and PDL-1 Inhibitors Price by Application (2018-2024) & (US$/Unit)
Table 55. Global PD-1 and PDL-1 Inhibitors Sales by Application (2024-2029) & (K Units)
Table 56. Global PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Application (2024-2029)
Table 57. Global PD-1 and PDL-1 Inhibitors Sales by Application (2024-2029) & (US$ Million)
Table 58. Global PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Application (2024-2029)
Table 59. Global PD-1 and PDL-1 Inhibitors Price by Application (2024-2029) & (US$/Unit)
Table 60. North America PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) (K Units)
Table 61. North America PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) (K Units)
Table 63. Europe PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) (K Units)
Table 67. Latin America PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 70. North America PD-1 and PDL-1 Inhibitors Sales by Country (2018-2024) & (K Units)
Table 71. North America PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 72. North America PD-1 and PDL-1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 73. North America PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 74. North America PD-1 and PDL-1 Inhibitors Sales by Country (2024-2029) & (K Units)
Table 75. North America PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 76. North America PD-1 and PDL-1 Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 77. North America PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 78. Europe PD-1 and PDL-1 Inhibitors Sales by Country (2018-2024) & (K Units)
Table 79. Europe PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe PD-1 and PDL-1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 82. Europe PD-1 and PDL-1 Inhibitors Sales by Country (2024-2029) & (K Units)
Table 83. Europe PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 84. Europe PD-1 and PDL-1 Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 85. Europe PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 86. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales by Region (2024-2029) & (K Units)
Table 91. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 92. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 93. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 94. Latin America PD-1 and PDL-1 Inhibitors Sales by Country (2018-2024) & (K Units)
Table 95. Latin America PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America PD-1 and PDL-1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America PD-1 and PDL-1 Inhibitors Sales by Country (2024-2029) & (K Units)
Table 99. Latin America PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 100. Latin America PD-1 and PDL-1 Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 101. Latin America PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 102. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Country (2024-2029) & (K Units)
Table 107. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 108. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 109. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 110. GlaxoSmithKline plc Company Information
Table 111. GlaxoSmithKline plc Introduction and Business Overview
Table 112. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product
Table 114. GlaxoSmithKline plc Recent Development
Table 115. Bristol-Myers Squibb Company Company Information
Table 116. Bristol-Myers Squibb Company Introduction and Business Overview
Table 117. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product
Table 119. Bristol-Myers Squibb Company Recent Development
Table 120. Arcus Biosciences, Inc. Company Information
Table 121. Arcus Biosciences, Inc. Introduction and Business Overview
Table 122. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product
Table 124. Arcus Biosciences, Inc. Recent Development
Table 125. Agenus Inc Company Information
Table 126. Agenus Inc Introduction and Business Overview
Table 127. Agenus Inc PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Agenus Inc PD-1 and PDL-1 Inhibitors Product
Table 129. Agenus Inc Recent Development
Table 130. F. Hoffmann-La Roche Ltd Company Information
Table 131. F. Hoffmann-La Roche Ltd Introduction and Business Overview
Table 132. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product
Table 134. F. Hoffmann-La Roche Ltd Recent Development
Table 135. Astra Zeneca PLC Company Information
Table 136. Astra Zeneca PLC Introduction and Business Overview
Table 137. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product
Table 139. Astra Zeneca PLC Recent Development
Table 140. Beigene Ltd Company Information
Table 141. Beigene Ltd Introduction and Business Overview
Table 142. Beigene Ltd PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Beigene Ltd PD-1 and PDL-1 Inhibitors Product
Table 144. Beigene Ltd Recent Development
Table 145. Incyte Corporation Company Information
Table 146. Incyte Corporation Introduction and Business Overview
Table 147. Incyte Corporation PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Incyte Corporation PD-1 and PDL-1 Inhibitors Product
Table 149. Incyte Corporation Recent Development
Table 150. Biocad Company Information
Table 151. Biocad Introduction and Business Overview
Table 152. Biocad PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Biocad PD-1 and PDL-1 Inhibitors Product
Table 154. Biocad Recent Development
Table 155. CStone Pharmaceuticals Company Information
Table 156. CStone Pharmaceuticals Introduction and Business Overview
Table 157. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product
Table 159. CStone Pharmaceuticals Recent Development
Table 160. Ono Pharmaceutical Company Information
Table 161. Ono Pharmaceutical Introduction and Business Overview
Table 162. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product
Table 164. Ono Pharmaceutical Recent Development
Table 165. Merck Company Information
Table 166. Merck Introduction and Business Overview
Table 167. Merck PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Merck PD-1 and PDL-1 Inhibitors Product
Table 169. Merck Recent Development
Table 170. Shanghai Junshi Bioscience Co. Ltd Company Information
Table 171. Shanghai Junshi Bioscience Co. Ltd Introduction and Business Overview
Table 172. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product
Table 174. Shanghai Junshi Bioscience Co. Ltd Recent Development
Table 175. Shanghai Henlius Biotech, Inc. Company Information
Table 176. Shanghai Henlius Biotech, Inc. Introduction and Business Overview
Table 177. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product
Table 179. Shanghai Henlius Biotech, Inc. Recent Development
Table 180. Jiangsu HengRui Medicine Co., Ltd. Company Information
Table 181. Jiangsu HengRui Medicine Co., Ltd. Introduction and Business Overview
Table 182. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product
Table 184. Jiangsu HengRui Medicine Co., Ltd. Recent Development
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. PD-1 and PDL-1 Inhibitors Market Trends
Table 188. PD-1 and PDL-1 Inhibitors Market Drivers
Table 189. PD-1 and PDL-1 Inhibitors Market Challenges
Table 190. PD-1 and PDL-1 Inhibitors Market Restraints
Table 191. PD-1 and PDL-1 Inhibitors Distributors List
Table 192. PD-1 and PDL-1 Inhibitors Downstream Customers
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-1 and PDL-1 Inhibitors Product Picture
Figure 2. Global PD-1 and PDL-1 Inhibitors Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global PD-1 and PDL-1 Inhibitors Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global PD-1 and PDL-1 Inhibitors Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Pembrolizumab
Figure 6. Global Pembrolizumab Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Nivolumab
Figure 8. Global Nivolumab Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Atezolizumab
Figure 10. Global Atezolizumab Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Durvalumab
Figure 12. Global Durvalumab Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of Avelumab
Figure 14. Global Avelumab Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Global PD-1 and PDL-1 Inhibitors Sales by Type (2018-2029) & (US$ Million)
Figure 16. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Type in 2022 & 2029
Figure 17. North America PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 18. North America PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 19. Europe PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 20. Europe PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 23. Latin America PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 24. Latin America PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-1 and PDL-1 Inhibitors Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-1 and PDL-1 Inhibitors Revenue in 2022
Figure 29. PD-1 and PDL-1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Stomach Cancer
Figure 31. Global Stomach Cancer Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Liver Cancer
Figure 33. Global Liver Cancer Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Kidney Ccancer
Figure 35. Global Kidney Ccancer Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Product Picture of Bladder Cancer
Figure 37. Global Bladder Cancer Sales YoY Growth (2018-2029) & (K Units)
Figure 38. Product Picture of Cervical Cancer
Figure 39. Global Cervical Cancer Sales YoY Growth (2018-2029) & (K Units)
Figure 40. Product Picture of Other
Figure 41. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 42. Global PD-1 and PDL-1 Inhibitors Sales by Application (2018-2029) & (US$ Million)
Figure 43. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application in 2022 & 2029
Figure 44. North America PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 45. North America PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 46. Europe PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 47. Europe PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 50. Latin America PD-1 and PDL-1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 51. Latin America PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. PD-1 and PDL-1 Inhibitors Manufacturing Cost Structure
Figure 55. PD-1 and PDL-1 Inhibitors Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed